Clinical Trials Logo

Blepharitis clinical trials

View clinical trials related to Blepharitis.

Filter by:

NCT ID: NCT04858113 Recruiting - Blepharitis Clinical Trials

Short-term Effects on Tear Film (Baby Shampoo vs Blephasol)

Blepha
Start date: October 1, 2018
Phase: N/A
Study type: Interventional

Lid cleansing is the standard regime that is recommended for the management of blepharitis in the UK and beyond. Whilst many successful commercial preparations exist, and some with clinical evidence, professional guidelines (UK Royal College of Ophthalmologists, UK College of Optometrists, AAO, etc.) continue to advocate the use of a diluted solution of baby shampoo, despite no clinical evidence of its safety, tolerance or long term effectiveness, and despite a statement form the manufacturers that it should not be used for this purpose. Where licensed, registered products exist it seems bizarre that we have this situation, but a Cochrane review from 2012 indicated that only a longitudinal, randomized controlled trial against baby shampoo would alter their conclusions. Whilst that sort of clinical study is possible, it is proposed here to start with a short-term study to look at the immediate changes induced in the tear film and ocular surface when comparing baby shampoo with Blephasol solution, in a blind, randomized controlled trial.

NCT ID: NCT04784091 Completed - Blepharitis Clinical Trials

Trial to Evaluate the Safety and Efficacy of TP-03 for the Treatment of Demodex Blepharitis

Saturn-2
Start date: April 29, 2021
Phase: Phase 3
Study type: Interventional

The purpose of this study is to compare the safety and efficacy of TP-03, an eyedrop, to its vehicle control for the treatment of blepharitis due to Demodex, a microscopic mite frequently found in human hair follicles.

NCT ID: NCT04780165 Completed - Demodex Blepharitis Clinical Trials

Efficacy and Tolerability of Blephademodex Wipes

Start date: September 11, 2019
Phase: N/A
Study type: Interventional

Primary Objective - To evaluate efficacy of Blephademodex eyelid hygiene wipe treatment with a subsequent maintenance period with Blephaclean lid cleansing wipes in Demodex blepharitis, as assessed by the change in ocular symptoms by a Global Discomfort Scale (GDS). Secondary Objectives - To evaluate the efficacy of Blephademodex eyelid hygiene wipe treatment in Demodex blepharitis as assessed by the change alone and in combination with a subsequent maintenance period of treatment with Blephaclean eyelid cleansing wipes ocular symptoms by: adapted TOSS; SANDE; specific blepharitis symptoms; Demodex count; ocular surface redness (Efron scale); lid margin redness/swelling (Efron / custom scale); Dandruff coverage at bases of eyelashes; ocular surface staining (Oxford scale; corneal only) - To evaluate subject and physician satisfaction with Blephademodex eyelid hygiene wipes - To evaluate ease of use for Blephademodex eyelid hygiene wipes - Adverse events are documented and analyzed.

NCT ID: NCT04742855 Recruiting - Blepharitis Clinical Trials

Probiotics for Blepharitis in Adults and Children

Start date: January 18, 2021
Phase:
Study type: Observational

The alteration of the intestinal microbiota through the use of specific probiotics can improve the clinical course of blepharitis by restoring intestinal and immune homeostasis. The purpose of this study is to define the possible positive impact of probiotics on patients with blepharitis.

NCT ID: NCT04678531 Completed - Clinical trials for Seborrheic Blepharitis

TTO Swabs Versus Baby Shampoo in Patients With Seborrehic Blepharitis

Start date: November 12, 2018
Phase: Phase 4
Study type: Interventional

The aim of the study was to compare the efficacy of lid swabs containing tea tree oil (TTO) and chamomile oil and baby shampoo (BS) in the treatment of seborrheic blepharitis.

NCT ID: NCT04675242 Completed - Blepharitis Clinical Trials

Study Evaluating the Safety and Efficacy of NCX 4251 Ophthalmic Suspension for the Treatment of Blepharitis

Mississippi
Start date: December 14, 2020
Phase: Phase 2
Study type: Interventional

This is a multi-center, randomized, double-masked, placebo-controlled, Phase 2b trial evaluating the safety and efficacy of NCX 4251 (fluticasone propionate nanocrystal) Ophthalmic Suspension 0.1% QD for the treatment of acute exacerbations of blepharitis.

NCT ID: NCT04603222 Recruiting - Blepharitis Clinical Trials

Evaluation of SUMMIT BRUSH in Treatment of Blepharitis

Start date: July 21, 2020
Phase: N/A
Study type: Interventional

Dry Eye Disease (DED) is a multifactorial disease that affects ~15-30 million people in the USA alone. It creates an enormous societal and economic burden, decreases productivity in the workplace, and affects the quality of lives of the people affected by this disease. DED is primarily caused by blepharitis, a chronic inflammation of the eyelid margins. If left untreated, blepharitis results in the obstruction and loss of the glands responsible for tear film production. The standard of care is the use of self-administered at home commercially available products, e.g., eyelid foams, gels, and pads. Although these products are helpful, they have limitations. Patients often require expensive in office procedures, e.g., lid debridement with exfoliation devices or more expensive procedures. The scope of this project is to evaluate the effectiveness of a new self-administered disposable ocular brush used in conjunction with the most common eyelid cleanser. The investigators are looking to see if combining the microexfoliation provided by the brush with the eyelid cleanser is more effective at removing the eyelid debris than the cleanser alone.

NCT ID: NCT04475432 Completed - Blepharitis Clinical Trials

Safety and Efficacy of TP-03 for the Treatment of Demodex Blepharitis

Saturn-1
Start date: September 9, 2020
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of this study is to compare the safety and efficacy of TP-03, 0.25%, an eyedrop, to its vehicle control for the treatment of blepharitis due to Demodex, a microscopic mite frequently found in human hair follicles. The hypothesis for the study is the proportion of participants cured at Day 43 with treatment by TP-03, 0.25%, is greater than the proportion cured by treatment with its vehicle.

NCT ID: NCT04469998 Completed - Clinical trials for Meibomian Gland Dysfunction

Evaluation of AXR-270 for the Treatment of Posterior Blepharitis Associated With Meibomian Gland Dysfunction

Start date: June 16, 2020
Phase: Phase 2
Study type: Interventional

This study will evaluate the safety, tolerability and efficacy of AXR-270 Cream in treating posterior blepharitis associated with Meibomian Gland Disease (MGD)

NCT ID: NCT04441528 Completed - Clinical trials for Seborrheic Blepharitis

Lid Wipes Versus Baby Shampoo in Patients With Seborrehic Blepharitis

Start date: November 1, 2018
Phase: Phase 4
Study type: Interventional

The purpose of this study is to investigate the efficacy of lid wipes containing terpinen-4-ol and sodium hyaluronate (Hy-ter®) for the treatment of seborrheic blepharitis compared to baby shampoo.